1. 2019
  2. In vitro investigation of the anti-NASH properties of elafibranor and lanifibranor using a human stem cell-derived disease model

    Joost Boeckmans (Speaker), Vera Rogiers (Contributor), Tamara Vanhaecke (Contributor), Robim Marcelino Rodrigues (Contributor)
    25 Feb 201926 Feb 2019

    Activity: Talk or presentationTalk or presentation at a conference

  3. 2018
  4. Application of a human skin stem cell-derived in vitro liver model of non-alcoholic steatohepatitis

    Joost Boeckmans (Speaker), Valerie Vandenbempt (Contributor), Karolien Buyl (Contributor), Alessandra Natale (Contributor), Joery De Kock (Contributor), Vera Rogiers (Contributor), Tamara Vanhaecke (Contributor), Robim Marcelino Rodrigues (Contributor)
    16 Oct 2018

    Activity: Talk or presentationTalk or presentation at a conference

  5. Untargeted in vitro metabolomics to identify hepatotoxic models of action

    Matthias Cuykx (Speaker), C. Beirnaert (Contributor), Robim Marcelino Rodrigues (Contributor), K. Laukens (Speaker), Tamara Vanhaecke (Contributor), A. Covaci (Contributor)
    20 Sep 2018

    Activity: Talk or presentationTalk or presentation at a conference

  6. Untargeted in vitro metabolomics to identify hepatotoxic modes of action

    Matthias Cuykx (Speaker), Charlie Beirnaert (Contributor), Robim Marcelino Rodrigues (Contributor), Kris Laukens (Speaker), Tamara Vanhaecke (Contributor), Adrian Covaci (Speaker)
    20 Sep 2018

    Activity: Talk or presentationTalk or presentation at a conference

  7. Untargeted in vitro metabololics to identify hepatotoxic modes of action

    Matthias Cuykx (Speaker), C Beirnaert (Speaker), Robim Marcelino Rodrigues (Speaker), K Laukens (Speaker), Tamara Vanhaecke (Speaker), Adrian Covaci (Speaker)
    19 Sep 201820 Sep 2018

    Activity: Talk or presentationTalk or presentation at a conference

  8. Untargeted in vitro metabolomics to identify hepatotoxic modes of action

    Matthias Cuykx (Speaker), C Beirnaert (Speaker), Robim Marcelino Rodrigues (Speaker), K Laukens (Speaker), Tamara Vanhaecke (Speaker), Adrian Covaci (Speaker)
    19 Sep 2018

    Activity: Talk or presentationTalk or presentation at a conference

  9. Investigation of drug-induced cholestasis using HepaRG cells and untargeted LC-MS metabolomics

    Matthias Cuykx (Speaker), Charlie Beirnaert (Speaker), Robim Marcelino Rodrigues (Speaker), Kris Laukens (Speaker), Tamara Vanhaecke (Speaker), Adrian Covaci (Speaker)
    3 Sep 2018

    Activity: Talk or presentationTalk or presentation at a conference

  10. The investigation of drug-induced cholestasis in HepaRG cells using untargeted LC-MS cholestasis

    Matthias Cuykx (Speaker), C Beirnaert (Speaker), Robim Marcelino Rodrigues (Speaker), K Laukens (Speaker), Tamara Vanhaecke (Speaker), Adrian Covaci (Speaker)
    2 Sep 20185 Sep 2018

    Activity: Talk or presentationTalk at an external academic organisation

  11. The investigation of drug-induced cholestasis in HepaRG cells using untargeted LC-MS metabolomics

    Matthias Cuykx (Speaker), C Beirnaert (Speaker), Robim Marcelino Rodrigues (Speaker), K Laukens (Speaker), Tamara Vanhaecke (Speaker), A Covaci (Speaker)
    2 Sep 20185 Sep 2018

    Activity: Talk or presentationTalk or presentation at a conference

  12. In vitro modelling of NAFLD using stem cells: state of the art

    Joost Boeckmans (Speaker), Alessandra Natale (Contributor), Karolien Buyl (Contributor), Joery De Kock (Contributor), Vera Rogiers (Contributor), Tamara Vanhaecke (Contributor), Robim Marcelino Rodrigues (Contributor)
    22 Mar 2018

    Activity: Talk or presentationTalk or presentation at a conference

Previous 1 2 3 4 5 6 7 8 ...29 Next

ID: 46467